Tudora Adelina, Lungeanu Diana, Pop-Moldovan Adina, Puschita Maria, Lala Radu I
Arad County Clinical Emergency Hospital, 310037 Arad, Romania.
Faculty of Medicine, "Vasile Goldis" Western University, 310025 Arad, Romania.
Healthcare (Basel). 2023 Apr 20;11(8):1183. doi: 10.3390/healthcare11081183.
Three years since the COVID-19 pandemic started, there is still little information about patients with chronic medical conditions, such as cardiovascular diseases (CVDs), who become infected with SARS-CoV-2. A retrospective analysis was performed to evaluate the impact of the COVID-19 pandemic on patients with cardiovascular comorbidities hospitalized with positive RT-PCR results for SARS-CoV-2 during the highest peaks of the first three pandemic waves: April 2020, October 2020, and November 2021. The primary outcome was in-hospital mortality; the secondary outcomes were length of hospitalization and required mechanical ventilation to assess the disease severity. Data were extracted from the hospital electronic database system: 680 eligible cases were identified out of 2919 patients. Mortality was the highest in wave 3 (31.9%) compared to the previous waves (13.6% and 25.8%). Hospitalization was also significantly longer in wave 3 (11.58 ± 5.34 vs. 8.94 ± 4.74 and 10.19 ± 5.06; < 0.001), and so was the need for mechanical ventilation (21.7% vs. 8.2% and 9%; < 0.001). Older age and male gender were confirmed as highly significant predictors of unfavorable outcomes. Ischemic heart disease worsened the odds of patients' survival irrespective of the three pandemic waves (Breslow-Day test, = 0.387), with a marginally significant Mantel-Haenszel common estimate for risk: OR = 1.604, 95% (0.996; 2.586). The significantly worse outcomes in wave 3 could have been influenced by a combination of factors: the low percentage of vaccinations in Romanian population, the more virulent delta strain, and pandemic attrition in the care provided to these patients with chronic CVDs.
自新冠疫情爆发三年以来,关于患有慢性疾病(如心血管疾病,CVD)的患者感染新冠病毒(SARS-CoV-2)的信息仍然很少。进行了一项回顾性分析,以评估新冠疫情对在前三个疫情高峰(2020年4月、2020年10月和2021年11月)期间因SARS-CoV-2 RT-PCR检测呈阳性而住院的心血管合并症患者的影响。主要结局是住院死亡率;次要结局是住院时间和需要机械通气以评估疾病严重程度。数据从医院电子数据库系统中提取:在2919名患者中确定了680例符合条件的病例。与前几波(13.6%和25.8%)相比,第三波的死亡率最高(31.9%)。第三波的住院时间也明显更长(11.58±5.34天,而前两波分别为8.94±4.74天和10.19±5.06天;P<0.001),机械通气的需求也是如此(21.7%,而前两波分别为8.2%和9%;P<0.001)。年龄较大和男性被确认为不良结局的高度显著预测因素。无论在三个疫情波次中,缺血性心脏病都会降低患者的生存几率(Breslow-Day检验,P = 0.387),风险的Mantel-Haenszel共同估计值略有显著差异:OR = 1.604,95%置信区间(0.996;2.586)。第三波明显更差的结局可能受到多种因素的综合影响:罗马尼亚人口中疫苗接种率较低、更具毒性的德尔塔毒株以及对这些慢性心血管疾病患者提供的护理中的疫情损耗。